Prevalence of HIV infection among pregnant women in Newfoundland

CMAJ. Canadian Medical Association Journal

Volumn 154, Issue 7, 1996, Pages 1027-1032

  Ratnam, Samuel ^a   Hogan, Kevin ^b   Hankins, Catherine ^c  

^a Newfoundland and Labrador Public Health Laboratory   (Canada)

^b New Janeway Childrens Health and Rehabilitation Centre   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CANADA; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; INDUCED ABORTION; PREGNANCY; PRENATAL CARE;

EID: 0029929354     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brookmeyer R: Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991; 253: 37-42
2. Gwinn M, Pappaioanou M, George R et al: Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA 1991; 265: 1704-1708
3. Nicoll A, Hutchinson E, Soldan K et al: Survey of human immunodeficiency virus infection among pregnant women in England and Wales: 1990-93. Commun Dis Rep 1994; 4: R115-R120
4. McLaws ML, Brown ARD, Cunningham PA et al: Prevalence of maternal HIV infection based on anonymous testing of neonates, Sydney 1989 Med J Aust 1990; 153: 383-386
5. Tappin DM, Girdwood RWA, Follett EAC et al: Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Lancet 1991; 337: 1565-1567
6. Ratnam S, Hankins C: The Newfoundland prenatal study of HIV seroprevalence. [abstract] Can J Infect Dis 1994; 5 (suppl D): 42D
7. Federal Centre for AIDS: Guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence research. Can Med Assoc J 1990; 143: 625-627
8. Inventory of HIV Seroprevalence Studies in Canada, Division of HIV/AIDS Epidemiology, Laboratory Centre for Disease Control, Health Canada, Ottawa, Nov 1993
9. Institute of Medicine, National Academy of Sciences: Confronting AIDS: Directions for Public Health, Health Care, and Research, National Academy Press, Washington, 1986: 51, 69, 306
10. Francis DP, Chin J: The prevention of acquired immunodeficiency syndrome in the United States: an objective strategy for medicine, public health, business, and the community JAMA 1987; 257: 1357-1366
11. Prevots DR, Ancelle-Park RA, Neal JJ et al. The epidemiology of heterosexually acquired HIV infection and AIDS in Western industrialized countries. AIDS 1994, 8 (suppl 1): S109-S117
12. AIDS - A Perspective for Canadians, Summary Report and Recommendations, Royal Society of Canada, Ottawa, 1988
13. Schechter MT, Ballem PJ, Buskard NA et al: An anonymous seroprevalence survey of HIV infection among pregnant women in British Columbia and the Yukon Territory. Can Med Assoc J 1990; 143: 1187-1192
14. Manitoba HIV seroprevalence study. Can Dis Wkly Rep 1991; 17: 179-184
15. Coates RA, Frank JW, Arshinoff R et al: The Ontario HIV seroprevalence study of childbearing women: results from the first year of testing. Clin Invest Med 1992; 15: 1-7
16. Hankins CA, Laberge C, Lapointe N et al: HIV infection among Quebec women giving birth to live infants. Can Med Assoc J 1990; 143: 885-893
17. Montpetit M, Ratnam S: Canadian HIV/AIDS strain surveillance program (CHASSP): Newfoundland. [abstract 121] Can J Infect Dis 1995; 6 (suppl B): 16B
18. Minkoff HL, Landesman SH: The case for routinely offering prenatal testing for human immunodeficiency virus. Am J Obstet Gynecol 1988; 159: 793-796
19. Barbacci M, Repke JT, Chaisson RE: Routine prenatal screening for HIV infection. Lancet 1991; 337: 709-711
20. Wilfert CM: Mandatory screening of pregnant women for the human immunodeficiency virus. Clin Infect Dis 1994; 19: 664-666
21. HIV and AIDS Provincial Statistics 1984-1994, Department of Health, Government of Newfoundland, St. John's, 1995
22. Quarterly Surveillance Update, Division of HIV/AIDS Epidemiology, Laboratory Centre for Disease Control, Health Canada, Ottawa Jan 1995
23. Recommendations of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 1994; 43: 1-20
24. Gushue J: Newfoundland's AIDS experience different from that in other provinces. Can Med Assoc J 1992; 147: 337-339